Form 4 for BMY Bristol Myers Squibb
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-20 · accession 0000014272-25-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-20 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | P - Purchase | $55.05 | +2,000 | 104.6K | +2% | +$110.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2025-02-20 | P | A | 2,000 | $55.05 | 104,626 | D | — | — |